C07D 213/82
In position 3
Official title: in position 3
C07D213/82 (In position 3) appears on 1,975 US grants and 1,924 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,975
- Published applications
- 1,924
- Assignees
- 862
- Inventors
- 6,434
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 23 | 0 |
| 1977 | 23 | 0 |
| 1978 | 21 | 0 |
| 1979 | 12 | 0 |
| 1980 | 19 | 0 |
| 1981 | 10 | 0 |
| 1982 | 15 | 0 |
| 1983 | 19 | 0 |
| 1984 | 11 | 0 |
| 1985 | 20 | 0 |
| 1986 | 15 | 0 |
| 1987 | 15 | 0 |
| 1988 | 18 | 0 |
| 1989 | 29 | 0 |
| 1990 | 37 | 0 |
| 1991 | 33 | 0 |
| 1992 | 34 | 0 |
| 1993 | 18 | 0 |
| 1994 | 19 | 0 |
| 1995 | 22 | 0 |
| 1996 | 19 | 0 |
| 1997 | 33 | 0 |
| 1998 | 39 | 0 |
| 1999 | 34 | 0 |
| 2000 | 40 | 0 |
| 2001 | 64 | 23 |
| 2002 | 73 | 64 |
| 2003 | 55 | 100 |
| 2004 | 57 | 119 |
| 2005 | 48 | 96 |
| 2006 | 62 | 83 |
| 2007 | 48 | 96 |
| 2008 | 57 | 78 |
| 2009 | 53 | 93 |
| 2010 | 59 | 100 |
| 2011 | 68 | 92 |
| 2012 | 71 | 84 |
| 2013 | 72 | 70 |
| 2014 | 79 | 86 |
| 2015 | 63 | 88 |
| 2016 | 72 | 91 |
| 2017 | 74 | 80 |
| 2018 | 56 | 56 |
| 2019 | 52 | 52 |
| 2020 | 36 | 52 |
| 2021 | 35 | 58 |
| 2022 | 22 | 45 |
| 2023 | 28 | 63 |
| 2024 | 29 | 70 |
| 2025 | 43 | 47 |
| 2026 | 21 | 38 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Heterocyclic compound1 Sep 2026US 12,723,028 B2Takeda Pharmaceutical Company Limited
- Co-crystal of coenzyme QH and nicotinamide, preparation method therefor and use thereof25 Aug 2026US 12,715,832 B2Cocrystal Technology (Jiaxing) Co., Ltd.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Compounds and methods of use1 Oct 2026US 2026/0297089 A1Tango Therapeutics, Inc.
- Crystalline forms of (r)-2-amino-5-(4-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-2-methylphenyl)-n-isopropylnicotinamide and methods for using the same10 Sep 2026US 2026/0265199 A1HiberCell, Inc.
- Cancer treatments targeting cancer stem cells10 Sep 2026US 2026/0265200 A1Remedy Plan, Inc.
- Tyrosine kinase inhibitors3 Sep 2026US 2026/0258012 A1
- Compound serving as ddr1 kinase inhibitor, and medicine20 Aug 2026US 2026/0242343 A1Nippon Shinyaku Co., Ltd.
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007
- Nitrogen-containing aromatic derivatives135US 7,253,286 B2Eisai Co., Ltd. · 2007
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997